Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
3.05M
-
Shares change
-
+136K
-
Total reported value, excl. options
-
$72.7M
-
Value change
-
+$3.48M
-
Put/Call ratio
-
0.48
-
Number of buys
-
24
-
Number of sells
-
-17
-
Price
-
$23.86
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q4 2020
56 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q4 2020.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.05M shares
of 69.1M outstanding shares and own 4.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (883K shares), VANGUARD GROUP INC (639K shares), NORTHERN TRUST CORP (239K shares), STATE STREET CORP (230K shares), GEODE CAPITAL MANAGEMENT, LLC (209K shares), GRIFFIN ASSET MANAGEMENT, INC. (86.8K shares), Invesco Ltd. (65K shares), Nuveen Asset Management, LLC (61.7K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (51.9K shares), and Parametric Portfolio Associates LLC (44.4K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.